2025-07-15 - Analysis Report
Okay, here's an analysis of Procter & Gamble (PG) based on the provided data, formatted for a concise English report.

**Report: Procter & Gamble (PG) Analysis**

**1. Performance Overview**

*   **Company Description:** Procter & Gamble Co. is a global consumer goods corporation that manufactures and markets a wide range of branded consumer products.
*   **Cumulative Return vs. S&P 500 (VOO):**
    *   PG: 46.08%
    *   VOO: 95.85%
    *   Difference: -45.6%
    *   Relative Difference: 0.8 (PG is positioned near the lowest end of its historical relative performance range compared to the S&P 500.)
*   **Alpha/Beta Analysis:**

| Year       | CAGR   | MDD    | Alpha   | Beta   | Cap(B) |
| ---------- | ------ | ------ | ------- | ------ | ------ |
| 2015-2017  | 21.0%  | 7.9%   | -8.0%   | 0.0    | 215.4  |
| 2016-2018  | 5.0%   | 56.7%  | -13.0%  | 0.1    | 215.5  |
| 2017-2019  | 30.0%  | 56.7%  | 0.0%    | 0.5    | 292.8  |
| 2018-2020  | 38.0%  | 59.1%  | 18.0%   | 0.3    | 326.2  |
| 2019-2021  | 56.0%  | 59.1%  | 8.0%    | 0.3    | 383.5  |
| 2020-2022  | 24.0%  | 74.7%  | 22.0%   | 0.3    | 355.3  |
| 2021-2023  | 30.0%  | 74.7%  | 12.0%   | 0.3    | 343.6  |
| 2022-2024  | 8.0%   | 74.7%  | -17.0%  | 0.3    | 393.1  |
| 2023-2025  | -14.0% | 71.6%  | -61.0%  | 0.2    | 360.5  |

*   **Analysis:** PG has significantly underperformed the S&P 500. The Alpha values are consistently negative or low, indicating underperformance relative to the benchmark after accounting for market risk (Beta). The recent years (2022-2025) show a particularly sharp decline in performance. The Beta values are relatively low, suggesting PG is less volatile than the overall market. MDD(Max Draw Down) is increasing every year.

**2. Recent Stock Price Movements**

*   **Current Price:** 153.76
*   **Recent Change:** -2.09 (Price dropped significantly compared to the previous close)
*   **Moving Averages:**
    *   5-day MA: 156.68
    *   20-day MA: 159.11
    *   60-day MA: 162.03

*   **Analysis:** The stock price is currently below all three moving averages, suggesting a short-term downtrend. The recent price drop is notable and potentially concerning.

**3. Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.3372 (Low Risk)
*   **RSI:** 29.02 (Oversold)
*   **PPO:** -0.2486
*   **Hybrid Signal:** cash_1%_Buy 80% of cash (27 shares - Caution - MRI:0.34) (Cash Ratio: 1% on 2025-07-07)
*   **Recent Relative Divergence Change:** 0.8 (+) Short-term Increase
*   **Expected Return:** 792.4% (Long-term, relative to S&P 500)

*   **Analysis:** The RSI indicates the stock is oversold, which *could* suggest a potential for a rebound. However, the PPO is negative, reinforcing the downward trend. The Hybrid Signal suggests a cautious buying opportunity. Despite recent struggles, the projected long-term return is very high. The significant price change of -2.09 (from previous close of 157.05 to 153.76) warrants attention, suggesting a possible catalyst for the recent downward movement.

**4. Recent News & Significant Events**

*   **Key Headlines:** Recent volatility, analyst discussions of performance in light of industry trends, and general market events affecting PG.

*   **Analysis:** These news items suggest that PG is currently facing headwinds and increased scrutiny, potentially contributing to the recent price volatility.

**5. Recent Earnings Analysis**

| 날짜       | EPS  | 매출      |
| ---------- | ---- | --------- |
| 2025-04-24 | 1.58 | 19.78 B$  |
| 2025-01-22 | 1.94 | 21.88 B$  |
| 2024-10-18 | 1.65 | 21.74 B$  |
| 2024-04-19 | 1.56 | 20.20 B$  |
| 2025-04-24 | 1.56 | 20.20 B$  |

*   **Analysis:** While EPS and revenue figures fluctuate, the most recent quarter shows a decline in both. This could be a contributing factor to the stock's recent poor performance.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter    | Revenue   | Profit Margin |
| ---------- | --------- | ------------- |
| 2025-03-31 | $19.78B  | 50.98%        |
| 2024-12-31 | $21.88B  | 52.39%        |
| 2024-09-30 | $21.74B  | 52.06%        |
| 2024-06-30 | $20.53B  | 49.60%        |
| 2024-03-31 | $20.20B  | 51.20%        |

**Capital and Profitability:**

| Quarter    | Equity    | ROE     |
| ---------- | --------- | ------- |
| 2025-03-31 | $52.27B  | 7.21%   |
| 2024-12-31 | $51.17B  | 9.05%   |
| 2024-09-30 | $51.84B  | 7.64%   |
| 2024-06-30 | $50.29B  | 6.24%   |
| 2024-03-31 | $50.06B  | 7.50%   |

*   **Analysis:** Revenue has decreased in the most recent quarter, and the Profit Margin has also slightly decreased. Equity is fluctuating, and ROE has decreased in the most recent quarter.

**7. Overall Analysis and Conclusion**

Procter & Gamble (PG) is currently facing challenges. It has significantly underperformed the S&P 500, and its recent stock price movement reflects a downward trend. Recent news headlines suggest increased scrutiny and volatility. The latest earnings and financial data indicate a decline in revenue, EPS, and ROE.

However, the MRI indicates low market risk, the RSI suggests the stock is oversold, and the Hybrid Signal hints at a potential buying opportunity. Furthermore, the long-term expected return is very high.

**Recommendation:** Given the mixed signals, a cautious approach is warranted. While the long-term potential is attractive, investors should closely monitor the company's performance, news, and industry trends before making any investment decisions. The current downturn may present a buying opportunity for long-term investors, but the recent negative momentum should not be ignored. Further investigation into the reasons behind the recent price drop and earnings decline is crucial.

